Trial · NCT03448549
SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
NCT03448549, Phase 3, Unknown, Peking University Cancer Hospital & Institute
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients. Trials, record NCT03448549. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03448549
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
- NCT number
- NCT03448549
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 1,191 participants, estimated
- Lead sponsor
- Peking University Cancer Hospital & Institute
- Conditions
- Colorectal Cancer Stage III, Adjuvant Chemotherapy
- Interventions
- Oxaliplatin, Tegafur，gimeracil and oteracil potassium, Xeloda
- First posted
- 2018-02-28
- Last updated
- 2020-03-06
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 3 year disease free survival | 3 years | 3 year disease free survival |
| Secondary | major adverse event -short term | 6 month after randomiztion (period during post-operational chemotherapy) | short term adverse reaction is defined as the as event within 3 months after chemotherapy,will be graded using the NCI Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. |
| Secondary | major adverse reaction-long term | upto 24 months | long term adverse reaction is defined as the as event 3 months after chemotherapy will be graded using the NCI Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. |
| Secondary | 3 year overall survival | 3 years | 3 year overall survival |
| Secondary | The accuracy of assessment of preoperative CT images on the stage | within 3 months before surgery | The accuracy of assessment of preoperative CT images on the stage(T and N) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03448549
GET https://conductscience.org/api/trials/v1/NCT03448549/registered